cyclosporine and Plasmablastic Diffuse Large B-cell Lymphoma

cyclosporine has been researched along with Plasmablastic Diffuse Large B-cell Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goh, YT; Gopalakrishnan, S; Grigoropoulos, NF; Ho, LP; Hwang, WYK; Lee, YS; Nagarajan, C; Phipps, C; Yeoh, KW1

Other Studies

1 other study(ies) available for cyclosporine and Plasmablastic Diffuse Large B-cell Lymphoma

ArticleYear
Durable remission is achievable with localized treatment and reduction of immunosuppression in limited stage EBV-related plasmablastic lymphoma.
    Annals of hematology, 2017, Volume: 96, Issue:11

    Topics: Aged; Brentuximab Vedotin; Combined Modality Therapy; Cyclosporine; Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunoconjugates; Immunosuppression Therapy; Kidney Transplantation; Lymphoma, Large-Cell, Immunoblastic; Male; Neoplasm Staging; Plasmablastic Lymphoma; Radiotherapy; Remission Induction

2017